GlassScriptPhysician profile
Jonathan C Amspacher
NPI 1154527190
$1,444.30
in general payments reported to CMS, 2019-2025
20 companies · $242 in 2025
The $242 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $124 · 2021: $246 · 2022: $12.33 · 2023: $228 · 2024: $226 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $696.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $696.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $253.07 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Axogen | $183.58 | 2023 | Avance Nerve Graft |
| Endo Pharmaceuticals INC. | $157.96 | 2019-2022 | |
| Avita Medical Americas, LLC | $152.60 | 2024 | |
| Rti Surgical, INC | $130.02 | 2025 | |
| Allergan, INC. | $90.12 | 2019-2020 | |
| Janssen Biotech, INC. | $81.47 | 2021-2025 | Tremfya |
| Lilly USA, LLC | $61.39 | 2019-2020 | |
| Leo Pharma INC. | $38.49 | 2019-2021 | |
| Endo USA, INC. | $37.24 | 2025 | Xiaflex |
| Abbvie INC. | $34.20 | 2024-2025 | |
| Amgen INC. | $33.92 | 2020-2021 | |
| Polynovo North America LLC | $28.91 | 2024 | Novosorb Btm |
| Kci USA, INC. | $28.52 | 2019 | |
| Kerecis Limited | $25.86 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $25.80 | 2021 | |
| Baxter Healthcare | $24.46 | 2019 | |
| Acera Surgical, INC. | $20.87 | 2025 | Restrata Wound Matrix |
| Solventum Corporation | $18.16 | 2025 | Prevena, Activ.A.C. |
| Integra Lifesciences Corporation | $17.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Amspacher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.